Viral Impacts on MR1 Antigen Presentation to MAIT Cells.


Journal

Critical reviews in immunology
ISSN: 1040-8401
Titre abrégé: Crit Rev Immunol
Pays: United States
ID NLM: 8914819

Informations de publication

Date de publication:
2021
Historique:
entrez: 5 4 2022
pubmed: 1 1 2021
medline: 8 4 2022
Statut: ppublish

Résumé

Mucosal-associated invariant T (MAIT) cells are abundant innate-like T cells important in antimicrobial immunity. These cells express a semi-invariant T cell receptor that recognizes the Major Histocompatibility Complex (MHC) class I-related protein 1 (MR1) in complex with small metabolite antigens derived from a range of commensal and pathogenic bacteria and yeasts, but not other pathogens such as viruses. Thus, MR1 stimulation of MAIT cells was thought to act as a sensor of bacterial infection and was not directly involved in anti-viral immunity. Surprisingly, viruses have recently been shown to directly impair MR1 antigen presentation by targeting the intracellular pool of MR1 for degradation. In this review, we summarize our current understanding of viral evasion of MR1 presentation pathway, and contrast this to evasion of other related MHC molecules. We examine MAIT cell activity in viral infection with a focus on the role of TCR-mediated activation of these innate-like cells and speculate on the selective pressure for viral evasion of MR1 antigen presentation. Overall, viral evasion of MR1 presentation uncovers a new avenue of research and implies that the MR1-MAIT cell axis is more important in viral immunity than was previously appreciated.

Identifiants

pubmed: 35381139
pii: 0059a42b37df2c08,3a726cf120e51426
doi: 10.1615/CritRevImmunol.2022041981
doi:

Substances chimiques

Histocompatibility Antigens Class I 0
MR1 protein, human 0
Minor Histocompatibility Antigens 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-67

Auteurs

Carolyn Samer (C)

Infection, Immunity and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Charles Perkins Centre, University of Sydney, Australia.

Renee Traves (R)

Infection, Immunity and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Charles Perkins Centre, University of Sydney, Australia; Sydney Institute for Infectious Diseases, University of Sydney, Australia.

Shivam K Purohit (SK)

Infection, Immunity and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Charles Perkins Centre, University of Sydney, Australia.

Allison Abendroth (A)

Infection, Immunity and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Charles Perkins Centre, University of Sydney, Australia; Sydney Institute for Infectious Diseases, University of Sydney, Australia.

Hamish E G McWilliam (HEG)

Department of Microbiology and Immunology, The University of Melbourne, at The Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.

Barry Slobedman (B)

Infection, Immunity and Inflammation, School of Medical Sciences, Faculty of Medicine and Health, Charles Perkins Centre, University of Sydney, Australia; Sydney Institute for Infectious Diseases, University of Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH